Alzheimer Disease, Early Onset
1 competing product in clinical development for Alzheimer Disease, Early Onset.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| 50 mg PTI-125 + 100 mg PTI-125 + 200 mg PTI-125 | Cassava Sciences | Phase 1 | Completed | 25 |